Clinical trial
Evaluation of the Cytokine 's Profile Following SarsCov 2 Infection (COVID-19) in Hemodialysis Patients
NCT05307601 is registered in ClinicalTrials.gov with AURA Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Cytokine 's Profile Following SarsCov 2 Infection (COVID-19) in Hemodialysis Patients
- Lead sponsor
- AURA Paris
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 1, 2020
- Completion date
- October 30, 2021
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, cytokine storm, dialysis; complications